Molecular biologic techniques in cytopathologic diagnosis

Korean Journal of Pathology

Volumn 43, Issue 5, 2009, Pages 387-392

  Hwang, Tae Sook ^a  

^a Konkuk University School of Medicine   (South Korea)

Author keywords

Cytopathologic diagnosis; Molecular biologic technique

Indexed keywords

EID: 77951175694     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2009.43.5.387     Document Type: Review

References (31)

1. Salto-Tellez M, Koay ES. Molecular diagnostic cytopathology: definitions, scope and clinical utility. Cytopathology 2004; 15: 252-5.
2. Greiner TC. Polymerase chain reaction: uses and potential applications in cytology. Diagn Cytopathol 1992; 8: 61-4.
3. Pestaner JP, Bibbo M, Bobroski L, Seshamma T, Bagasra O. Potential of the in situ polymerase chain reaction in diagnostic cytology. Acta Cytol 1994; 38: 676-80.
4. Al Shanqeety O, Mourad WA. Diagnosis of peripheral T-cell lymphoma by fine needle aspiration biopsy: a cytomorphologic and immunophenotypic approach. Diagn Cytopathol 2000; 23: 375-9.
5. Eng C, Brody LC, Wagner TM, et al. Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. J Med Genet 2001; 38: 824-33.
6. Conley YP, Brockway H, Beatty M, Kerr ME. Qualitative and quantitative detection of mitochondrial heteroplasmy in cerebrospinal fluid using denaturing high-performance liquid chromatography. Brain Res Brain Res Protoc 2003; 12: 99-103.
7. Liu W, Smith DI, Rechtzigel KJ, Thibodeau SN, James CD. Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res 1998; 26: 1396-400.
8. Gross E, Arnold N, Pfeifer K, Bandick K, Kiechle M. Identification of specific BRCA1 and BRCA2 variants by DHPLC. Hum Mutat 2000; 16: 345-53.
9. Jones AC, Sampson JR, Hoogendoorn B, Cohen D, Cheadle JP. Application and evaluation of denaturing HPLC for molecular genetic analysis in tuberous sclerosis. Hum Genet 2000; 106: 663-8.
10. Bausch B, Koschker AC, Fassnacht M, et al. Comprehensive mutation scanning of NF1 in apparently sporadic cases of pheochromocytoma. J Clin Endocrinol Metab 2006; 91: 3478-81.
11. Kim IJ, Kim K, Kang HC, Jang SG, Park JG. DHPLC analysis of adenomatous polyposis coli (APC) mutations using ready-to-use APC plates: simple detection of multiple base pair deletion mutations. Genet Test 2008; 12: 295-8.
12. Sapio MR, Posca D, Troncone G, et al. Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA). Eur J Endocrinol 2006; 154: 341-8.
13. Zhu D, Xing D, Tang Y, Zhang L. A novel mutant allele specific amplification and electrochemiluminescence method for the detection of point mutation in clinical samples. Biosens Bioelectron 2009; 24: 3306-10.
14. Dennis Lo YM, Virginia A, Horton. Artificial Restriction Fragment Length Polymorphism (A-RFLP) Analysis. Methods Mol Med 1998; 16: 71-9.
15. Hayashida N, Namba H, Kumagai A, et al. A rapid and simple detection method for the BRAF (T1796A) mutation in fine-needle aspirated thyroid carcinoma cells. Thyroid 2004; 14: 910-5.
16. Chung KW, Yang SK, Lee GK, et al. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Clin Endocrinol 2006; 65: 660-6.
17. Kim SK, Kim DL, Han HS, et al. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules. Diagn Mol Pathol 2008; 17: 118-25.
18. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-7.
19. Agaton C, Unneberg P, Sievertzon M, et al. Gene expression analysis by signature pyrosequencing. Gene 2002; 289: 31-9.
20. Fakhrai-Rad H, Pourmand N, Ronaghi M. Pyrosequencing: an accurate detection platform for single nucleotide polymorphisms. Hum Mutat 2002; 19: 479-85.
21. Garcia CA, Ahmadian A, Gharizadeh B, Lundeberg J, Ronaghi M, Nyrén P. Mutation detection by pyrosequencing: sequencing of exons 5-8 of the p53 tumor suppressor gene. Gene 2000; 253: 249-57.
22. Ahmadian A, Gharizadeh B, Gustafsson AC, et al. Single nucleotide polymorphism analysis by pyrosequencing. Anal Biochem 2000; 280: 103-10.
23. Jo YS, Huang S, Kim YJ, et al. Diagnostic value of pyrosequencing for the BRAF V600E mutation in ultrasound-guided fine-needle aspiration biopsy samples of thyroid incidentalomas. Clin Endocrinol 2009; 70: 139-44.
24. Takano T, Ohe Y, Sakamoto H, et al. Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer. J Clin Oncol 2005; 23: 6829-37.
25. Ogino S, Kawasaki T, Brahmandam M. Sensitive sequencing method for KRAS mutation detection by pyrosequencing. J Mol Diagn 2005; 7: 413-21.
26. Bickmann JK, Kamin W, Wiebel M, et al. A novel approach to CFTR mutation testing by pyrosequencing-based assay panels adapted to ethnicities. Clin Chem 2009; 55: 1083-91.
27. Zhang L, Kirchhoff T, Yee CJ, Offit K. A rapid and reliable test for BRCA1 and BRCA2 founder mutation analysis in paraffin tissue using pyrosequencing. J Mol Diagn 2009; 11: 176-81.
28. Ogino S, Nosho K, Kirkner GJ, et al. PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer. J Clin Oncol 2009; 27: 1477-84.
29. Colella S, Shen L, Baggerly KA, Issa JP, Krahe R. Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites. Biotechniques 2003; 35: 146-50.
30. Tan YH, Liu Y, Eu KW, et al. Detection of BRAF V600E mutation by pyrosequencing. Pathology 2008; 40: 295-8.
31. Chun JY, Kim KJ, Hwang IT, et al. Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene. Nucleic Acids Res 2007; 35: e40.